Theravance Biopharma (TBPH) Prepaid Assets (2013 - 2026)

Theravance Biopharma (TBPH) has reported Prepaid Assets for 14 consecutive years, with $7.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Prepaid Assets rose 82.05% year-over-year to $7.4 million; the TTM figure through Mar 2026 stood at $7.4 million (up 82.05% YoY), while the FY2025 annual figure was $7.6 million, up 76.85% from the prior year.
• Prepaid Assets slipped to $7.4 million in Q1 2026 per TBPH's latest filing, from $7.6 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $11.6 million in Q4 2023 and bottomed at $4.1 million in Q1 2025.
• Historically, Prepaid Assets has averaged $7.0 million across 5 years, with a median of $7.4 million in 2026.
• Annual changes were most pronounced in 2024 — Prepaid Assets sank 63.14% — and 2026, when it soared 82.05%.
• Theravance Biopharma's Prepaid Assets stood at $7.7 million in 2022, then soared by 51.04% to $11.6 million in 2023, then tumbled by 63.14% to $4.3 million in 2024, then jumped by 76.85% to $7.6 million in 2025, then decreased by 2.38% to $7.4 million in 2026.
• Business Quant data shows TBPH's Prepaid Assets at $7.4 million in Q1 2026, $7.6 million in Q4 2025, and $6.8 million in Q3 2025.